Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.

S Seitz; F G Rick; A V Schally; A Treszl; Florian Hohla; L Szalontay; M Zarandi; O Ortmann; J B Engel; S Buchholz

doi:10.3892/or.2013.2435

Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.

S Seitz, F G Rick, A V Schally, A Treszl, Florian Hohla (Co-author), L Szalontay, M Zarandi, O Ortmann, J B Engel, S Buchholz

Research output: Contribution to journal › Original Article › peer-review

26 Citations (Web of Science)

Original language	English
Pages (from-to)	413-418
Journal	ONCOLOGY REPORTS
Volume	30
Issue number	1
DOIs	https://doi.org/10.3892/or.2013.2435
Publication status	Published - 2013

Keywords

HORMONE-RELEASING-HORMONE
BENIGN PROSTATIC HYPERPLASIA
ACTIVATED PROTEIN-KINASE
GROWTH-HORMONE
SPLICE VARIANTS
CELL-PROLIFERATION
EXPRESSION
RECEPTOR
INHIBITION
AKT

Access to Document

10.3892/or.2013.2435

Cite this

Seitz, S., Rick, F. G., Schally, A. V., Treszl, A., Hohla, F., Szalontay, L., Zarandi, M., Ortmann, O., Engel, J. B., & Buchholz, S. (2013). Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers. ONCOLOGY REPORTS , 30(1), 413-418. https://doi.org/10.3892/or.2013.2435

Seitz, S ; Rick, F G ; Schally, A V et al. / Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers. In: ONCOLOGY REPORTS 2013 ; Vol. 30, No. 1. pp. 413-418.

@article{b8d4b86133d740d99c28bd3c652bcc85,

title = "Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.",

keywords = "HORMONE-RELEASING-HORMONE, BENIGN PROSTATIC HYPERPLASIA, ACTIVATED PROTEIN-KINASE, GROWTH-HORMONE, SPLICE VARIANTS, CELL-PROLIFERATION, EXPRESSION, RECEPTOR, INHIBITION, AKT",

author = "S Seitz and Rick, {F G} and Schally, {A V} and A Treszl and Florian Hohla and L Szalontay and M Zarandi and O Ortmann and Engel, {J B} and S Buchholz",

year = "2013",

doi = "10.3892/or.2013.2435",

language = "English",

volume = "30",

pages = "413--418",

journal = "ONCOLOGY REPORTS ",

issn = "1021-335X",

number = "1",

}

Seitz, S, Rick, FG, Schally, AV, Treszl, A, Hohla, F, Szalontay, L, Zarandi, M, Ortmann, O, Engel, JB & Buchholz, S 2013, 'Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.', ONCOLOGY REPORTS , vol. 30, no. 1, pp. 413-418. https://doi.org/10.3892/or.2013.2435

Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers. / Seitz, S; Rick, F G; Schally, A V et al.
In: ONCOLOGY REPORTS , Vol. 30, No. 1, 2013, p. 413-418.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.

AU - Seitz, S

AU - Rick, F G

AU - Schally, A V

AU - Treszl, A

AU - Hohla, Florian

AU - Szalontay, L

AU - Zarandi, M

AU - Ortmann, O

AU - Engel, J B

AU - Buchholz, S

PY - 2013

Y1 - 2013

KW - HORMONE-RELEASING-HORMONE

KW - BENIGN PROSTATIC HYPERPLASIA

KW - ACTIVATED PROTEIN-KINASE

KW - GROWTH-HORMONE

KW - SPLICE VARIANTS

KW - CELL-PROLIFERATION

KW - EXPRESSION

KW - RECEPTOR

KW - INHIBITION

KW - AKT

U2 - 10.3892/or.2013.2435

DO - 10.3892/or.2013.2435

M3 - Original Article

C2 - 23624870

SN - 1021-335X

VL - 30

SP - 413

EP - 418

JO - ONCOLOGY REPORTS

JF - ONCOLOGY REPORTS

IS - 1

ER -

Seitz S, Rick FG, Schally AV, Treszl A, Hohla F, Szalontay L et al. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers. ONCOLOGY REPORTS . 2013;30(1):413-418. doi: 10.3892/or.2013.2435